Collective Family Office’s AbbVie ABBV Stock Holding History

Collective Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Sell	4,506 -166	-4%	-$35.7K	0.23%	74
2026 Q1	$1.02M	Sell	4,672 -750	-14%	-$166K	0.23%	72
2025 Q4	$1.24M	Sell	5,422 -134	-2%	-$30.5K	0.28%	69
2025 Q3	$1.29M	Sell	5,556 -38	-0.7%	-$7.74K	0.31%	65
2025 Q2	$1.04M	Sell	5,594 -303	-5%	-$56.3K	0.27%	74
2025 Q1	$1.24M	Sell	5,897 -438	-7%	-$85.1K	0.33%	61
2024 Q4	$1.13M	Sell	6,335 -252	-4%	-$46.3K	0.31%	65
2024 Q3	$1.3M	Sell	6,587 -243	-4%	-$45.4K	0.35%	61
2024 Q2	$1.17M	Sell	6,830 -120	-2%	-$19.9K	0.34%	67
2024 Q1	$1.27M	Sell	6,950 -174	-2%	-$30K	0.41%	55
2023 Q4	$1.1M	Sell	7,124 -85	-1%	-$12.4K	0.39%	59
2023 Q3	$1.07M	Sell	7,209 -705	-9%	-$103K	0.42%	58
2023 Q2	$1.07M	Sell	7,914 -575	-7%	-$84.3K	0.42%	57
2023 Q1	$1.35M	Sell	8,489 -390	-4%	-$59.6K	0.56%	48
2022 Q4	$1.43M	Sell	8,879 -1,804	-17%	-$277K	0.64%	45
2022 Q3	$1.43M	Sell	10,683 -2,954	-22%	-$424K	0.71%	41
2022 Q2	$2.09M	Buy	13,637 +646	+5%	+$98.7K	0.9%	34
2022 Q1	$2.11M	Sell	12,991 -2,557	-16%	-$371K	0.8%	38
2021 Q4	$2.1M	Sell	15,548 -1,391	-8%	-$164K	0.83%	35
2021 Q3	$1.83M	Buy	16,939 +4	+0%	+$457	0.79%	34
2021 Q2	$1.91M	Sell	16,935 -899	-5%	-$101K	0.82%	34
2021 Q1	$1.93M	Buy	17,834 +1,777	+11%	+$190K	0.94%	33
2020 Q4	$1.72M	Buy	+16,057	New	+$1.54M	0.96%	29

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Collective Family Office's ABBV Position: Q2 2026 in Review

Collective Family Office reduced its AbbVie (ABBV) stake by 3.6% in Q2 2026, selling an estimated $35.7K and leaving 4,506 shares worth $1.13M. The position accounts for 0.23% of the portfolio, ranked #74.

Collective Family Office first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.11M in Q1 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Collective Family Office held 4,506 shares of AbbVie worth $1.13M as of Q2 2026.
Collective Family Office sold 166 AbbVie shares in Q2 2026, an estimated $35.7K.
AbbVie made up 0.23% of Collective Family Office's portfolio in Q2 2026, its #74 holding.
Collective Family Office first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
Collective Family Office's AbbVie position peaked at $2.11M in Q1 2022.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Collective Family Office's 13F filing for Q2 2026, filed 2 Jul 2026.